At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted Aug 10, 2001·Updated Jul 29, 2016
In Brief
An observational study for Atherosclerosis and 4 related conditions. Completed.
Detailed Summary
To test whether novel cardiovascular risk factors are related to the presence and development of atherosclerosis and macrovascular events in Type 2 diabetes mellitus and to determine whether intensive glucose lowering therapy will reduce the levels of these cardiovascular risk factors.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis, Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Non-insulin Dependent, Heart Diseases
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2001
First PostedAug 2001
Primary CompletionNov 2005
TodayJul 2026
First PostedAug 10, 2001
Enrollment StartApr 1, 2001
Primary CompletionNov 1, 2005
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 24.9 years ago